Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Sensitivity in T1DM, MODY2, and Normal Controls
NCT02971202Phase 1Completed
- Sponsor
- Vanderbilt University
- Start
- Dec 2016
- Primary completion
- Feb 2019
- Countries
- 1
01
Overview
Phase 1, open-label trial (3 arms), sponsored by Vanderbilt University. Primary endpoint: Whole-body Glucose Utilization at 8 hours. Started Dec 2016; status: completed.
Beyond the preview
Go deeper on NCT02971202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02971202.